Literature DB >> 26638682

Alzheimer's Disease: An Exacerbation of Senile Phenoptosis.

N K Isaev1, E V Stelmashook, E E Genrikhs, M V Oborina, M R Kapkaeva, V P Skulachev.   

Abstract

Alzheimer's disease is characterized by progressive memory loss and cognitive decline accompanied by degeneration of neuronal synapses, massive loss of neurons in the brain, eventually resulting in complete degradation of personality and death. Currently, the cause of the disease is not fully understood, but it is believed that the person's age is the major risk factor for development of Alzheimer's disease. People who have survived after cerebral stroke or traumatic brain injury have substantially increased risk of developing Alzheimer's disease. Social exclusion, low social activity, physical inactivity, poor mental performance, and low level of education are among risk factors for development of this neurodegenerative disease, which is consistent with the concept of phenoptosis (Skulachev, V. P., et al. (1999) Biochemistry (Moscow), 64, 1418-1426; Skulachev, M. V., and Skulachev, V. P. (2014) Biochemistry (Moscow), 79, 977-993) stating that rate of aging is related to psychological and social aspects in human behavior. Here we assumed that Alzheimer's disease might be considered as an exacerbation of senile phenoptosis. If so, then development of this disease could be slowed using mitochondria-targeted antioxidants due to the accumulated data demonstrating a link between mitochondrial dysfunction and oxidative stress both with normal aging and Alzheimer's disease.

Entities:  

Mesh:

Year:  2015        PMID: 26638682     DOI: 10.1134/S0006297915120056

Source DB:  PubMed          Journal:  Biochemistry (Mosc)        ISSN: 0006-2979            Impact factor:   2.487


  4 in total

1.  Integrated analysis and network pharmacology approaches to explore key genes of Xingnaojing for treatment of Alzheimer's disease.

Authors:  Meixia Wang; Shouyong Wang; Yong Li; Gaomei Cai; Min Cao; Lanfang Li
Journal:  Brain Behav       Date:  2020-04-18       Impact factor: 2.708

2.  Differential Expression of mRNAs in the Brain Tissues of Patients with Alzheimer's Disease Based on GEO Expression Profile and Its Clinical Significance.

Authors:  Guowei Ma; Mingyan Liu; Ke Du; Xin Zhong; Shiqiang Gong; Linchi Jiao; Minjie Wei
Journal:  Biomed Res Int       Date:  2019-02-26       Impact factor: 3.411

3.  Immune abnormalities and differential gene expression in the hippocampus and peripheral blood of patients with Alzheimer's disease.

Authors:  Xiaonan Wang; Di Wang; Fei Su; Chunmei Li; Min Chen
Journal:  Ann Transl Med       Date:  2022-01

4.  Ganoderma lucidum Triterpenoids (GLTs) Reduce Neuronal Apoptosis via Inhibition of ROCK Signal Pathway in APP/PS1 Transgenic Alzheimer's Disease Mice.

Authors:  Nanhui Yu; Yongpan Huang; Yu Jiang; Lianhong Zou; Xiehong Liu; Sulai Liu; Fang Chen; Jun Luo; Yimin Zhu
Journal:  Oxid Med Cell Longev       Date:  2020-01-28       Impact factor: 6.543

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.